Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma

Journal of the American Veterinary Medical Association

Volumn 228, Issue 4, 2006, Pages 549-552

  Upton, Melinda L ^a   Tangner, C H ^b   Payton, Mark E ^c  

^a Oncol/Int Med Referral Clinic   (United States)

^b Veterinary Surgery Center   (United States)

^c OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOXANTRONE; PIROXICAM;

ANIMAL EXPERIMENT; APPETITE DISORDER; ARTICLE; BLADDER; BLADDER CARCINOMA; CANCER SURVIVAL; CARBON DIOXIDE LASER; CONTROLLED STUDY; DOG; FEMALE; INTERMETHOD COMPARISON; LASER SURGERY; LETHARGY; MALE; NONHUMAN; TRANSITIONAL CELL CARCINOMA; URETHRA; URETHRA CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; CARBON DIOXIDE; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOG DISEASES; DOGS; FEMALE; LASER SURGERY; MALE; MITOXANTRONE; PIROXICAM; REMISSION INDUCTION; TREATMENT OUTCOME; URETHRAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

ANIMALIA; CANIS FAMILIARIS;

EID: 32544433474     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.228.4.549     Document Type: Article

References (21)

1. Norris AM, Laing EJ, Valli VE, et al. Canine bladder and urethral tumors: a retrospective study of 115 cases (1980-1985). J Vet Intern Med 1992;6:145-153.
2. Knapp DW, Glickman NW, DeNicola DB, et al. Naturally occurring canine transitional cell carcinoma of the urinary bladder. A relevant model of human invasive bladder cancer. Urol Oncol 2000;5:47-59.
3. Stone EA, George TF, Gilson SD, et al. Partial cystectomy for urinary bladder neoplasia: surgical technique and outcome in 11 dogs. J Small Anim Pract 1996;37:480-485.
4. Stone EA, Withrow SJ, Page RL, et al. Ureterocolonic anastamosis in ten dogs with transitional cell carcinoma. Vet Surg 1988;17:147-153.
5. White RN, Daview JV, Gregory SP. Vaginourethroplasty for treatment of urethral obstruction in the bitch. Vet Surg 1996;25:503-510.
6. Schwartz PD, Egger EL, Klause SE. Modified "cup-patch" ileocystoplasty for urinary bladder reconstruction in a dog. J Am Vet Med Assoc 1991;198:273-277.
7. Helfand SC, Hamilton TA, Hungerford LL, et al. Comparison of three treatments for transitional cell carcinoma of the bladder in the dog. J Am Anim Hosp Assoc 1994;30:270-275.
8. Lengerich EJ, Teclaw RF, Mendlein M, et al. Pet populations in the catchment area of the Purdue Comparative Oncology Program. J Am Vet Med Assoc 1992;200:51-56.
9. Moore AS, Cardona A, Shapiro W, et al. Cisplatin (cisdiaminedichloroplatinum) for treatment of transitional cell carcinoma of the urinary bladder or urethra. A retrospective study of 15 dogs. J Vet Intern Med 1990;4:148-152.
10. Chun R, Knapp DW, Widmer WR, et al. Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1997;11:279-283,
11. Chun R, Knapp DW, Widmer WR, et al. Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983-1993). J Am Vet Med Assoc 1996;209:1588-1591.
12. Knapp DW, Richardson RC, Chan TC, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1994;8:273-278.
13. Knapp DW, Glickman NW, Widmer WR, et al. Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer. Cancer Chemother Pharmacol 2000;146:221-226.
14. Henry CJ, McCaw DL, Turnquist SE, et al. Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive bladder carcinoma. Clin Cancer Res 2003;9:906-911.
15. Poirier VJ, Forrest LJ, Adams WM, et al. Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study. J Am Anim Hosp Assoc 2004;40:131-136.
16. Wodnicki H, Goldberg R, Kaplan S, et al. The laser: an alternative for palliative treatment of obstructing intraluminal lesions. Am Surg 1988;54:227-230.
17. Bhatta KM. Lasers in urology. Lasers Surg Med 1995;16:312-330.
18. Sakkas G, Karagiannis A, Karayannis D, et al. Laser treatment in urology: our experience with neodymium:YAG and carbon dioxide lasers. Int Urol Nephrol 1995;27:405-412.
19. Dmitriev BV, Nikol'skii AD, Latyshev MM, et al. The surgical results in malignant bladder tumors using the scalpel-1 carbon-dioxide laser [in Russian]. Urol Nefrol (Mosk) 1997;1:25-28.
20. Wishnow KI, Johnson DE, Grignon DJ, et al. Denudation of the entire mucosa of the canine urinary bladder using the neodymium:YAG laser with the MTR 1.5 contact probe. Lasers Surg Med 1988;8:589-595.
21. Wishnow KI, Johnson DE, Grignon DJ, et al. Regeneration of the canine urinary bladder mucosa after complete surgical denudation. J Urol 1989;141:1476-1479.